Flavonoids and Their Relation to Human Health

Fruit and Vegetable Phytochemicals: Chemistry, Nutritional Value, and Stability

Volumn , Issue , 2009, Pages 155-175

  Robles Sardin, Alma E ^a   Bolaños Villar, Adriana Verónica ^a   González Aguilar, Gustavo A ^a   de la Rosa, Laura A ^b  

^a CENTRO DE INVESTIGACIÓN EN ALIMENTACIÓN Y DESARROLLO   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE CIUDAD JUÁREZ   (Mexico)

Author keywords

Antithrombotic and antiatherosclerotic effect; Bioactive phytochemicals in fruits and vegetables polyphenols and flavonoids; Cocoa consumption, hypotensive properties reduction in systolic and diastolic pressure; Flavonoids and antioxidant capacity; Flavonoids and cancer flavanone consumption and inverse relationship with cancer; Flavonoids and cardiovascular diseases; Flavonoids and their relation to human health; Flavonoids, prevention of onset of coronary disease; Fruit and vegetable extracts reducing vulnerability to oxidative stress; Nontransmittable chronic illnesses and oxidative agents in body

Indexed keywords

EID: 84859355464     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780813809397.ch6     Document Type: Chapter

References (137)

1. Adlercreutz H and Mazur W. 1997. Phyto-oestrogens and Western diseases. Ann Med 29(2):95-120.
2. Ahn WS, Yoo J, Huh SW, Kim CK, Lee JM, Namkoong SE, Bae SM and Lee IP. 2003. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev 12(5):383-390.
3. Alvarez Castro E and, Orallo Cambeiro F. 2003. Actividad biológica de los flavonoides (II). Acción cardiovascular y sanguínea. OFFARM 22:102-110.
4. Arts IC, Hollman PC, Bueno De Mesquita HB, Feskens EJ and Kromhout D. 2001. Dietary catechins and epithelial cancer incidence: the Zutphen elderly study. Int J Cancer 92(2):298-302.
5. Arts IC, Jacobs DR Jr., GrossM, Harnack LJ and Folsom AR. 2002a. Dietary catechins and cancer incidence among postmenopausal women: the IowaWomen's Health Study (United States). Cancer Causes Control 13(4):373-382.
6. Arts MJ, Haenen GR, Wilms LC, Beetstra SA, Heijnen CG, Voss HP, Bast A. 2002b. Interactions between flavonoids and proteins: effect on the total antioxidant capacity. J Agric Food Chem 50(5):1184-1187.
7. Aviram M and Fuhrman B. 2003. Effects of flavonoids on the oxidation of LDL and atherosclerosis. In: Rice-Evans C and Packer L, editors. Flavonoids in Health and Disease, 2nd ed. Boca Raton, FL: CRC Press, pp. 165-203.
8. Aviram M, Fuhrman B. 2002. Wine flavonoids protect against LDL oxidation and atherosclerosis. Ann N Y Acad Sci 957:146-161.
9. Bagli E, Stefaniotou M, Morbidelli L, Ziche M, Psillas K, Murphy C and Fotsis T. 2004. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity. Cancer Res 64(21):7936-7946.
10. Balasubramanian S, Govindasamy S. 1996. Inhibitory effect of dietary flavonol quercetin on 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Carcinogenesis 17(4):877-879.
11. Barringer TA, Hatcher L and Sasser HC. 2008. Potential benefits on impairment of endothelial function after a high-fat meal of 4 weeks of flavonoid supplementation. eCAM:1-6.
12. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G and Corti A. 2006. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 66(2):1234-1240.
13. Boots AW, HaenenGRMMand Bast A. 2008. Health effects of quercetin: From antioxidant to nutraceutical. Eur J Pharmacol 585:325-337.
14. Boston Collaborative Drug Surveillance Program. 1972. Coffee drinking and acute myocardial infarction. Report from the Boston Collaborative Drug Surveillance Program. Lancet 2:1278-1281.
15. Boyd NF, Lockwood GA, Martin LJ,Knight JA, Byng JW,Yaffe MJ and Tritchler DL. 1998. Mammographic densities and breast cancer risk. Breast Dis 10(3-4):113-126.
16. Brash AR. 2001. Arachidonic acid as a bioactive molecule. J Clin Invest 107(11):1339-1345.
17. Buijsse B, Feskens EJ, Kok FJ and Kromhout D. 2006. Cocoa intake, blood pressure, and cardiovascular mortality: the Zetphen Elderly Study. Arch Intern Med 166:411-417.
18. Cazarolli LH, Zanatta L, Alberton EH, Figueredo MS, Folador P, Damazio RG, Pizzolatti MG and Silva FR. 2008. Flavonoids: cellular and molecular mechanisms of action in glucose homeostasis. Mini Rev Med Chem 8(10):1032-1038.
19. Chen JJ, Ye ZQ and Koo MW. 2004. Growth inhibition and cell cycle arrest effects of epigallocatechin gallate in the NBT-II bladder tumour cell line. BJU Int 93(7):1082-1086.
20. Cho SY, Park SJ, Kwon MJ, Jeong TS, Bok SH, Choi WY, Jeong WI, Ryu SY, Do SH, Lee CS, Song JC and Jeong KS. 2003. Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-kappaB pathway in lipopolysaccharide-stimulated macrophage.Mol Cell Biochem 243(1-2):153- 160.
21. Chun OK, Chung SJ and Song WO. 2007. Estimated dietary flavonoid intake and major food sources of U.S. adults. J Nutr 37(5):1244-1252.
22. Coxam V. Phyto-oestrogens and bone health. 2008. Proc Nutr Soc 67(2):184-195.
23. de Luis DA and Aller R. 2008. Papel de los flavonoides del té en la protección cardiovascular. An Med Interna 25:105-107.
24. Dembinska-Kiec A, MykkanenO,Kiec-Wilk B and Mykkanen H. 2008. Antioxidant phytochemicals against type 2 diabetes. Br J Nut 99:ES109-ES117.
25. Ding EL, Hutfless SM, Ding X and Girotra S. 2006. Chocolate and prevention of cardiovascular diseases: a systematic review. Nutr Metab 3:2.
26. Duffy SJ, Keaney JF Jr, Holbrook M, Gokce N, Swerdloff PL, Frei B and Vita JA. 2001. Short- and longterm black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 104(2):151-156.
27. Engelman HM, Alekel DL, Hanson LN, Kanthasamy AG and Reddy MB. 2005. Blood lipid and oxidative stress responses to soy protein with isoflavones and phytic acid in postmenopausal women. Am J Clin Nutr 81:590-596.
28. Engler MB, Engler MM, Chen CY, Malloy MJ, Browne A, Chiu EY, Kwak HK, Milbury P, Paul SM, Blumberg J and Mietus-Snyder ML. 2004. Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr 23:197-204.
29. Erdman JW Jr, Balentine D, Arab L, Beecher G, Dwyer JT, Folts J, Harnly J, Hollman P, Keen CL, Mazza G, Messina M, Scalbert A, Vita J, Williamson G and Burrowes J. 2007. Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC. J Nutr 137:718S-737S.
30. flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol 165(5):514-523.
31. Frankel EN, Kanner J, German JB, Parks E and Kinsella JE. 1993. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341:454-457.
32. Freedman JE, Parker C 3rd, Li L, Perlman JA, Frei B, Ivanov V, Deak LR, Iafrati MD and Folts JD. 2001. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103:2792-2798.
33. Geleijnse JM and Hollman PCh. 2008. Flavonoids and cardiovascular health: which compounds, what mechanisms? Am J Clin Nutr 88(1):12-13.
34. Geleijnse JM, Launer LJ, Van Der Kuip DA, Hofman A and Witteman JC. 2002. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr 75:880-886.
35. Goldberg DM. 1995. Does wine work?. Clin Chem 1:14-16.
36. Goldbohm RA, Hertog MG, Brants HA, van Poppel G and van den Brandt PA. 1996. Consumption of black tea and cancer risk: a prospective cohort study. J Natl Cancer Inst 88(2):93-100.
37. Goldbohm RA, van den Brandt PA, Hertog MG, Brants HA and Van Poppel G. 1995. Flavonoid intake and risk of cancer: a prospective cohort study. Am J Epidemiol 41:s61.
38. Guo JY, Li X, Browning JD Jr., Rottinghaus GE, Lubahn DB, Constantinou A, Bennink M and MacDonald RS. 2004. Dietary soy isoflavones and estrone protect ovariectomized ERalphaKO and wild-type mice from carcinogen-induced colon cancer. J Nutr 134(1):179-182.
39. Haddad AQ, Venkateswaran V, Viswanathan L, Teahan SJ, Fleshner NE and Klotz LH. 2006. Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines. Prostate Cancer Prostatic Dis 9(1):68-76.
40. Hakim IA, Alsaif MA,AlduwaihyM,Al-Rubeaan K, Al-NuaimARandAl-Attas OS. 2003. Tea consumption and the prevalence of coronary heart disease in Saudi adults: results from a Saudi national study. Prev Med 36:64-70.
41. Hamalainen M, Nieminen R, Vuorela P, Heinonen M and Moilanen E. 2007. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin and daidzein inhibit STAT-1 and NF-kB activations whereas flavones, isorhamnetin, naringenins, and pelargonidin inhibit only NF-kB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophagues. Mediators Inflamm 2007:45673.
42. Herrera MD, Zarzuelo A, Jimenez J,Marhuenda E, Duarte J. 1996. Effects of flavonoids on rat aortic smooth muscle contractility: structure-activity relationships. Gen Pharmacol 27:273-277.
43. Hertog MG, Feskens EJ, Hollman PC, Katan MB and Kromhout D. 1993. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342:1007-1011.
44. Hertog MG, Feskens EJ, Hollman PC, Katan MB and Kromhout D. 1994. Dietary flavonoids and cancer risk in the Zutphen Elderly Study. Nutr Cancer 22(2):175-184.
45. Hertog MG, Feskens EJ and Kromhout D. 1997a. Antioxidant flavonols and coronary heart disease risk. Lancet 349:699.
46. Hertog MG, Sweetnam PM, Fehily AM, Elwood PC and Kromhout D. 1997b. Antioxidant flavonols and ischemic heart disease in aWelsh population ofmen: the Caerphilly Study.AmJ Clin Nutr 65:1489-1494.
47. Higdon JV and Frei B. 2003. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 43(1):89-143. Review.
48. Hirvonen T, Pietinen P, Virtanen M, Ovaskainen ML, Hakkinen S, Albanes D and Virtamo J. 2001. Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology 12:62-67.
49. Hollman PCH and Arts ICW. 2000. Flavonols, flavones and flavanols: nature, occurrence and dietary burden. J Sci Food Agric 80:1081-1093.
50. Hollman PC, Van Het Hof KH, Tijburg LB and Katan MB. 2001. Addition of milk does not affect the absorption of flavonols from tea in man. Free Radic Res 34:297-300.
51. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL and Cassidy A. 2008. Flavonoids, flavonoid-rich foods, and cardiovascular risk: ameta-analysis of randomized controlled trials. Am J Clin Nutr 88(1):38-50.
52. Huang MT, Xie JG, Wang ZY, Ho CT, Lou YR, Wang CX, Hard GC and Conney AH. 1997. Effects of tea, decaffeinated tea, and caffeine on UVB light-induced complete carcinogenesis in SKH-1 mice: demonstration of caffeine as a biologically important constituent of tea. Cancer Res 57(13):2623-2629.
53. Issa AY, Volate SR and Wargovich MJ. 2006. The role of phytochemicals in inhibition of cancer and inflammation: new directions and perspectives. J Food Comp Anal 19:405-419.
54. Itani SI, Ruderman NB, Schmieder F and Boden G. 2002. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51(7):2005-2011.
55. Jayaprakasam B, Vareed SK, Olson LK and Nair MG. 2005. Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits. J Agric Food Chem 53(1):28-31.
56. Johannot L and Somerset SM. 2006. Age-related variations in flavonoid intake and sources in the Australian population. Public Health Nutr 9:1045-1054.
57. Jonas JC, Plant TD, Gilon P, Detimary P, NenquinMand Henquin JC. 1995. Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets. Br J Pharmacol 114(4):872-880.
58. Joseph JA, Shukitt-Hale B, Denisova NA, Bielinski D, Martin A, McEwen JJ and Bickford PC. 1999. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 19(18):8114-8121.
59. Kavanagh KT, Hafer LJ, Kim DW, and others. 2001. Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem 82(3):387-398.
60. Kay CD, Mazza G and Holub BJ. 2005. Anthocyanins exist in the circulation primarily as metabolites in adult men. J Nutr 135:2582-2588.
61. Keli SO, Hertog MG, Feskens EJ,Kromhout D. 1996. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen Study. Arch Intern Med 156:637-642.
62. Keogh JB, McInerney J and Clifton PM. 2007. The effect of milk protein on the bioavailability of cocoa polyphenols. J Food Sci 72(3):S230-S233.
63. Kim MH. 2003. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrixdegrading proteases. J Cell Biochem 89(3):529-538.
64. Klaunig JE, Xu Y, Han C, Kamendulis LM, Chen J, Heiser C, Gordon MS andMohler ER. 1999. The effect of tea consumption on oxidative stress in smokers and nonsmokers. Proc Soc Exp Biol Med 220:249- 254.
65. Knekt P, Jarvinen R, Reunanen A and Maatela J. 1996. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 312:478-481.
66. Knekt P, Järvinen R, Seppänen R, Hellövaara M, Teppo L, Pukkala E and Aromaa A. 1997. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 146(3):223-230.
67. Knekt P, Kumpulainen J, Järvinen R, Rissanen H, Heliövaara M, Reunanen A, Hakulinen T and Aromaa A. 2002. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76(3):560-568.
68. Kong AN, Owuor E, Yu R, Hebbar V, Chen C, Hu R and Mandlekar S. 2001. Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE). Drug Metab Rev 33(3-4):255-271.
69. Kris-Etherton PMandKeen CL. 2002. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol 13(1):41-49.
70. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y and Tsuji I. 2006. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 296:1255-1265.
71. Kyle JA, Morrice PC, McNeill G and Duthie GG. 2007. Effects of infusion time and addition of milk on content and absorption of polyphenols from black tea. J Agric Food Chem 55:4889-4894.
72. Lagiou P, Rossi M, Lagiou A, Tzonou A, La Vecchia C and Trichopoulos D. 2008. Flavonoid intake and liver cancer: a case-control study in Greece. Cancer Causes Control 19(8):813-818.
73. Lagiou P, Samoli E, Lagiou A, Peterson J, Tzonou A, Dwyer J and Trichopoulos D. 2004a. Flavonoids, vitamin C and adenocarcinoma of the stomach. Cancer Causes Control 15:67-72.
74. Lagiou P, Samoli E, Lagiou A, Tzonou A, Kalandidi A, Peterson J, Dwyer J and Trichopoulos D. 2004b. Intake of specific flavonoid classes and coronary heart disease. A case-control study in Greece. Eur J Clin Nutr 58:1643-1648.
75. Lamuela-Raventós RM, Andrés-Lacueva C, Permanyer J and Izquierdo-Pulido M. 2001. More antioxidants in cocoa. J Nutr. 131(3):834-835.
76. Langley-Evans SC. 2000. Consumption of black tea elicits an increase in plasma antioxidant potential in humans. Int J Food Sci Nutr 51(5):309-315.
77. Lee KW, Kim YJ, Lee HJ and Lee CY. 2003. Cocoa has more phenolic phytochemicals and a higher antioxidant capacity than teas and red wine. J Agric Food Chem 51:7292-7295.
78. Leenen R, Roodenburg AJ, Tijburg LB and Wiseman SA. 2000. A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur J Clin Nutr 54:87-92.
79. Letenneur L, Proust-Lima C, Le Gouge A, Dartigues JF and Barberger-Gateau P. 2007. Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol 165(12):1364-1371.
80. Li ZG, Shimada Y, Sato F, Maeda M, Itami A, Kaganoi J, Komoto I, Kawabe A and Imamura M. 2002. Inhibitory effects of epigallocatechin-3-gallate on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats. Int J Oncol 21(6):1275-1283.
81. Lin J, Rexrode KM, Hu F, Albert CM, Chae CU, Rimm EB, Stampfer MJ and Manson JE. 2007. Dietary intakes of flavonols and flavones and coronary heart disease in US women. Am J Epidemiol 165:1305-1313.
82. Liu J, Ho Sc, Su Y, Chen W, Zhang C and Chen Y. 2009. Effect of long-term intervention of soy isoflavones on bone mineral density in women: A meta-analysis of randomized controlled trials. Bone Doi:10.1016/j.bone.2008.12.020.
83. Liu RH. 2003. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr 78(3 Suppl):517S-520S.
84. Lotito SB and Frei B. 2004. Relevance of apple polyphenols as antioxidants in human plasma: contrasting in vitro and in vivo effects. Free Radic Biol Med 36(2):201-211.
85. Lotito SB and Frei B. 2006. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic Biol Med 41(12):1727-1746.
86. Ma DF, Qin LQ, Wang PY and Katoh R. 2008. Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials. Clin Nutr 27(1):57-64.
87. Manach C, Scalbert A,Morand C, Rémésy C and Jimenez L. 2004. Polyphenols: food sources and bioavailability. Am J Clin Nutr 79:727-747.
88. Manach C, Williamson G, Morand C, Scalbert A and Rémésy C. 2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81(1 Suppl):230S- 242S.
89. Martin S, Favot L, Matz R, Lugnier C and Andriantsitohaina R. 2003. Delphinidin inhibits endothelial cell proliferation and cell cycle progression through a transient activation of ERK-1/-2. Biochem Pharmacol 65(4):669-675.
90. Martinez-Flores A, Gónzalez-Gallego J, Culebras JM and Tuñón MJ. 2002. Nutr Hosp 17:271-278.
91. McCullough ML, Robertson AS, Chao A, Jacobs EJ, Stampfer MJ, Jacobs DR, Diver WR, Calle EE and Thun MJ. 2003. A prospective study of whole grains, fruits, vegetables and colon cancer risk. Cancer Causes Control 14(10):959-970.
92. Mojzisová G and Kuchta M. 2001. Dietary flavonoids and risk of coronary heart disease. Physiol Res 50:529-535.
93. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K and van Leeuwen PA. 2001. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74(4):418-425.
94. Ohno T, Kato N, Ishii C, Shimizu M, Ito Y, Tomono S and Kawazu S. 1993. Genistein augments cyclic adenosine 3'5'-monophosphate(cAMP) accumulation and insulin release in MIN6 cells. Endocr Res 19(4):273-285.
95. O'Leary KA, de Pascual-Tereasa S, Needs PW, Bao YP, O'Brien NM and Williamson G. 2004. Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat Res 551(1-2):245-254.
96. Park Y, Subar AF, Kipnis V, Thompson FE,Mouw T, Hollenbeck A, LeitzmannMF and Schatzkin A. 2007. Fruit and vegetable intakes and risk of colorectal cancer in the NIH-AARP Diet and Health Study. Am J Epidemiol 166(2):170-180.
97. Pascarella L. 2007. Essentials of Daflon 500 mg: from early valve protection to long-term benefits in the management of chronic venous disease. Curr Pharm Des 13:431-444.
98. Persaud SJ, Harris TE, Burns CJ and Jones PM. 1999. Tyrosine kinases play a permissive role in glucoseinduced insulin secretion from adult rat islets. J Mol Endocrinol 22(1):19-28.
99. Peters U, Poole C and Arab L. 2001. Does tea affect cardiovascular disease? Ametaanalysis. AmJ Epidemiol 154:495-503.
100. Potenza MA, Marasciulo FL, Tarquinio M, Tiravanti E, Colantuono G, Federici A, Kim JA, Quon MJ and Montagnani M. 2007. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 292(5):E1378-E1387.
101. Ramos S. 2007. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 18(7):427-442.
102. Rein D, Lotito S, Holt R, Keen C, Schmitz H and Fraga C. 2000. Epicatechin in human plasma: in vivo determination and effect of chocolate consumption on plasma oxidation status. J Nutr 130:2109S-2114S.
103. Rimm EB,Katan MB,AscherioA, Stampfer MJ andWillett WC. 1996. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 125:384-389.
104. Rossi M, Garavello W, Talamini R, La Vecchia C, Franceschi S, Lagiou P, Zambon P, Dal Maso L, Bosetti C and Negri E. 2007. Flavonoids and risk of squamous cell esophageal cancer. International Journal of Cancer 120(7):1560-1564.
105. Roura E, Andrés-Lacueva C, Estruch R, Mata-Bilbao ML, Izquierdo-Pulido M, Waterhouse A Land Lamuela-Raventós RM. 2007. Milk does not affect the bioavailability of cocoa powder flavonoid in healthy human. Ann Nutr Metab 51(6):493-498.
106. Sah JF, Balasubramanian S, Eckert RL and Rorke EA. 2004. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem 279(13):12755-12762.
107. Sakata K, Hirose Y, Qiao Z, Tanaka T and Mori H. 2003. Inhibition of inducible isoforms of cyclooxygenase and nitric oxide synthase by flavonoid hesperidin in mouse macrophage cell line. Cancer Lett 199(2):139-145.
108. Sarria A. 2004. Flavonoides: compuestos bioactivos de los alimentos. Boletín Sociedad de Pediatría de Aragón, La Rioja Y Soria 34(3):88-92.
109. Sato M, Bagchi D, Tosaki A and Das DK. 2001. Grape seed proanthocyanidin reduces cardiomyocyte apoptosis by inhibiting ischemia/reperfusion-induced activation of JNK-1 and C-JUN. Free Radic Biol Med 31(6):729-737.
110. Satue-Gracia MT, Heinonen M and Frankel EN. 1997. Anthocyanins as antioxidants on human low-density lipoprotein and lecithin-liposome systems. J Agric Food Chem 45:3362-3367.
111. Schroeter H, Holt RR, Orozco TJ, Schmitz HH and Keen CL. 2003. Nutrition: milk and absorption of dietary flavanols. Nature 426(6968):787-788.
112. Schwartz JL, Baker V, Larios E and Chung FL. 2005. Molecular and cellular effects of green tea on oral cells of smokers: a pilot study. Mol Nutr Food Res 49(1):43-51.
113. Serafini M, Bugianesi R, Maiani G, Valtuena S, De Santis S and Crozier A. 2003. Plasma antioxidants from chocolate. Nature 424(6952):1013.
114. Sorenson RL, Brelje TC and Roth C. 1994. Effect of tyrosine kinase inhibitors on islets of Langerhans: evidence for tyrosine kinases in the regulation of insulin secretion. Endocrinology 134(4):1975-1978.
115. Steele VE, Hawk ET, Viner JL and Lubet RA. 2003. Mechanisms and applications of nonsteroidal antiinflammatory drugs in the chemoprevention of cancer. Mutat Res 523-524:137-144.
116. Stein JH, Keevil JG,Wiebe DA, Aeschlimann S and Folts JD. 1999. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 100:1050-1055.
117. Sung H, Nah J, Chun S, Park H, Yang SE and Min WK. 2000. In vivo antioxidant effect of green tea. Eur J Clin Nutr 54(7):527-529.
118. Teissedre PL, Frankel EN, Waterhouse AL, Peleg H and German JB. 1996. Inhibition of in vitro human LDL oxidation by phenolic antioxidants from grapes and wines. J Sci Food Agric 70:55-61.
119. Thomasset SC, Berry DP, Garcea G, Marczylo T, Steward WP and Gescher AJ. 2006. Dietary polyphenolic phytochemicals-promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer 120(3):451-458.
120. Valenzuela A, Arteaga A and Rozowski J. 2007. Rol de la dieta mediterránea en la prevalencia del syndrome metabólico. Revista Chilena de Nutrición 34(3): online version.
121. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M and Telser J. 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44-84.
122. van der Schouw YT, Kreijkamp-Kaspers S, Peeters PH, Keinan-Boker L, Rimm EB and Grobbee DE. 2005. Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk inWestern women. Circulation 111(4):465-471.
123. van Dokkum W, Frølich W, Saltmarsh M, Gee J. 2008. The health effects of bioactive plant components in food: results and opinions of the EU COST 926 action. Nutr Bull 33(2):133-139.
124. Venables MC, Hulston CJ, Cox HR and Jeukendrup AE. 2008. Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans. Am J Clin Nutr 87(3):778-784.
125. Visioli F, Borsani L and Galli C. 2000. Diet and prevention of coronary heart disease: the potential role of phytochemicals. Cardiovasc Res 47:419-425.
126. Voorrips LE, Goldbohm RA, van PoppelG, Sturmans F,Hermus RJJ and van den Brandt PA. 2000.Vegetable and fruit consumption and risks of colon and rectal cancer in a prospective cohort study. Am J Epidemiol 152:1081-1092.
127. Walle UK and Walle T. 2002. Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoidsstructural requirements. Drug Metab Dispos 30(5):564-569.
128. Wang J, Schramm D and Holt R. 2000. A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J Nutr 130:2115S-2119S.
129. Wang W, VanAlstyne PC, Irons KA, Chen S, Stewart JW and Birt DF. 2004. Individual and interactive effects of apigenin analogs on G2/M cell-cycle arrest in human colon carcinoma cell lines. Nutr Cancer 48(1):106-114.
130. Wang-Polagruto JF, Villablanca AC, Polagruto JA, Lee L, Holt RR, Schrader HR, Ensunsa JL, Steinberg FM, Schmitz HH and Keen CL. 2006. Chronic consumption of flavanol-rich cocoa improves endothelial function and decreases vascular cell adhesion molecule in hypercholesterolemic postmenopausal women. J Cardiovasc Pharmacol 47 Suppl 2: S177-186; discussion S206-209.
131. Wu LY, Juan CC, Ho LT, Hsu YP and Hwang LS. 2004. Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. J Agric Food Chem 52(3):643-648.
132. Yamagishi M, Natsume M, Osakabe N, and others. 2002. Effects of cacao liquor proanthocyanidins on PhIPinduced mutagenesis in vitro, and in vivo mammary and pancreatic tumorigenesis in female Sprague-Dawley rats. Cancer Lett 185(2):123-130.
133. Yamane T, Nakatani H, Kikuoka N, and others. 1996. Inhibitory effects and toxicity of green tea polyphenols for gastrointestinal carcinogenesis. Cancer 77(8 Suppl):1662-1667.
134. Yang CS, Landau JM, HuangMT and Newmark HL. 2001. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21:381-406. Review.
135. Yang CS, Yang GY, Landau JM, Kim S and Liao J. 1998. Tea and tea polyphenols inhibit cell hyperproliferation, lung tumorigenesis, and tumor progression. Exp Lung Res 24(4):629-639.
136. Yochum L, Kushi LH, Meyer K and Folsom AR. 1999. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol 149:943-949.
137. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW and Shulman GI. 2002. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 27;277(52):50230-50236.